Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|
| Total revenue | 19.20%383.74K | 428.16%321.94K | -48.20%60.96K | -77.97%117.67K | 534.03K |
| Operating revenue | 19.20%383.74K | 428.16%321.94K | -48.20%60.96K | -77.97%117.67K | --534.03K |
| Cost of revenue | -70.41%52.17K | 176.3K | |||
| Gross profit | 19.20%383.74K | 428.16%321.94K | -6.94%60.96K | -81.69%65.5K | 357.74K |
| Operating expense | 2.49%2.71M | 67.77%2.64M | -15.00%1.58M | -64.56%1.85M | 5.23M |
| Selling and administrative expenses | -12.13%1.85M | 118.38%2.11M | -26.43%966.11K | -70.57%1.31M | --4.46M |
| -General and administrative expense | -12.13%1.85M | 118.38%2.11M | -26.43%966.11K | -70.57%1.31M | --4.46M |
| Research and development costs | --346.21K | ---- | ---- | ---- | --178.17K |
| Depreciation amortization depletion | 10.58%313.52K | -41.95%283.53K | 22.19%488.38K | 59.24%399.68K | --250.99K |
| -Depreciation and amortization | 10.58%313.52K | -41.95%283.53K | 22.19%488.38K | 59.24%399.68K | --250.99K |
| Provision for doubtful accounts | ---- | ---- | ---- | -81.12%7.8K | --41.31K |
| Other operating expenses | -21.86%194.85K | 106.53%249.36K | -8.94%120.74K | -55.52%132.6K | --298.08K |
| Operating profit | -0.17%-2.32M | -53.26%-2.32M | 15.30%-1.51M | 63.31%-1.79M | -4.87M |
| Net non-operating interest income (expenses) | 337.22%39.54K | 106.98%9.04K | 18.59%-129.54K | 24.15%-159.11K | -209.77K |
| Non-operating interest income | 238.15%50.45K | -1.12%14.92K | -15.26%15.09K | -20.21%17.81K | --22.32K |
| Non-operating interest expense | 85.65%10.91K | -95.94%5.88K | -18.25%144.63K | -23.77%176.92K | --232.08K |
| Other net income (expenses) | 9,232.45%1.65M | -97.81%17.73K | 503.55%811.39K | 100.35%134.44K | -38.28M |
| Special income (charges) | ---129.41K | ---- | -545.54%-366.44K | 100.21%82.25K | ---38.28M |
| -Less:Impairment of capital assets | --129.41K | ---- | --366.44K | ---- | --38.28M |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --82.25K | ---- |
| Other non-operating income (expenses) | 9,962.28%1.78M | -98.49%17.73K | 2,156.78%1.18M | --52.19K | ---- |
| Income before tax | 72.52%-630.4K | -175.58%-2.29M | 54.07%-832.43K | 95.82%-1.81M | -43.37M |
| Income tax | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | |||||
| Net income | 67.25%-630.4K | -106.55%-1.92M | -238.21%-931.85K | 99.47%-275.52K | -51.93M |
| Net income continuous operations | 72.52%-630.4K | -175.58%-2.29M | 54.07%-832.43K | 95.82%-1.81M | ---43.37M |
| Net income discontinuous operations | ---- | 471.49%369.34K | -106.47%-99.42K | 117.95%1.54M | ---8.56M |
| Noncontrolling interests | |||||
| Net income attributable to the company | 67.25%-630.4K | -106.55%-1.92M | -238.21%-931.85K | 99.47%-275.52K | -51.93M |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | |||||
| Net income attributable to common stockholders | 67.25%-630.4K | -106.55%-1.92M | -238.21%-931.85K | 99.47%-275.52K | -51.93M |
| Diluted earnings per share | 0 | 0.00%-0.005 | -0.005 | 0 | -0.42 |
| Basic earnings per share | 0 | 0.00%-0.005 | -0.005 | 0 | -0.42 |
| Dividend per share | |||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |